GlassScriptPhysician profile
Corella A James-Johnson
NPI 1730114745
$1,439.96
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $680 · 2022: $710 · 2023: $27.97 · 2024: $22.07.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $50.04.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $50.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $266.68 | 2021-2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $153.11 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $131.43 | 2021-2022 | |
| Glaxosmithkline, LLC. | $129.84 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $108.15 | 2021-2022 | |
| Janssen Pharmaceuticals, INC | $95.97 | 2021 | |
| Abbott Laboratories | $84.42 | 2021-2022 | |
| Astellas Pharma US INC | $79.81 | 2021-2024 | Veozah |
| Lilly USA, LLC | $75.90 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $60.77 | 2021-2022 | |
| Pfizer INC. | $60.73 | 2021-2022 | |
| Esperion Therapeutics, INC. | $36.55 | 2021-2022 | |
| Sanofi-Aventis U.S. LLC | $32.60 | 2021-2022 | |
| Teleflex LLC | $27.97 | 2023 | Urolift |
| Otsuka America Pharmaceutical, INC. | $20.90 | 2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Xeris Pharmaceuticals, INC. | $17.05 | 2022 | |
| Biohaven Pharmaceuticals, INC. | $16.64 | 2021 | |
| Merck Sharp & Dohme LLC | $14.55 | 2022 | |
| Alvogen INC | $13.62 | 2022 | |
| Dexcom, INC. | $13.27 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Corella James-Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.